BR0314531A - Formulações apropriadas de derivados do ácido nodulispórico para combater parasitas - Google Patents
Formulações apropriadas de derivados do ácido nodulispórico para combater parasitasInfo
- Publication number
- BR0314531A BR0314531A BR0314531-0A BR0314531A BR0314531A BR 0314531 A BR0314531 A BR 0314531A BR 0314531 A BR0314531 A BR 0314531A BR 0314531 A BR0314531 A BR 0314531A
- Authority
- BR
- Brazil
- Prior art keywords
- nodulisporic acid
- acid derivatives
- relates
- appropriate formulations
- parasitic infestations
- Prior art date
Links
- UNCVXXVJJXJZII-QLETUHIQSA-N 1k1cu6363a Chemical class OC(=O)C(/C)=C/C=C/[C@@](C)([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@]1(C)[C@@H]2CC2=C1N1[C@@H](C(=C)C)C(=O)C3=C([C@@H](O)[C@@H]4C(OC(C)(C)C=C44)(C)C)C4=CC2=C31 UNCVXXVJJXJZII-QLETUHIQSA-N 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 244000045947 parasite Species 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 206010061217 Infestation Diseases 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 3
- 230000003071 parasitic effect Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000011938 amidation process Methods 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 229930187416 nodulisporic acid Natural products 0.000 abstract 1
- UNCVXXVJJXJZII-UHFFFAOYSA-N nodulisporic acid A Natural products C1CC2C(C)(C=CC=C(C)C(O)=O)C(O)CCC2(C)C2(C)C1CC1=C2N2C(C(=C)C)C(=O)C3=C(C(O)C4C(OC(C)(C)C=C44)(C)C)C4=CC1=C32 UNCVXXVJJXJZII-UHFFFAOYSA-N 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
- A01N43/38—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Wood Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
"FORMULAçõES APROPRIADAS DE DERIVADOS DO áCIDO NODULISPóRICO PARA COMBATER PARASITAS". Esta invenção refere-se, entre outras coisas, a composições de deposição cutânea para o tratamento ou a profilaxia de infestações parasitas em mamíferos ou pássaros que compreende: (1) pelo menos um derivado de ácido nodulispórico; (2) um veículo carreador líquido aceitável; e (3) opcionalmente, um inibidor de cristalização. A invenção também se refere um método de tratamento de infestações parasitas ou para a profilaxia de infestações parasitas em mamíferos ou pássaros que compreende aplicar por via tópica ao referido mamífero ou pássaro uma quantidade eficaz de uma composição de acordo com a presente invenção. Além disso, esta invenção refere-se a um processo de amidação para preparar derivados do tipo amida de ácido nodulispórico e ao intermediário formado neste processo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41562702P | 2002-10-02 | 2002-10-02 | |
| US10/618,975 US20040077703A1 (en) | 2002-10-02 | 2003-07-14 | Nodulisporic acid derivative spot-on formulations for combating parasites |
| PCT/US2003/030500 WO2004030457A1 (en) | 2002-10-02 | 2003-09-29 | Nodulisporic acid derivative spot-on formulations for combating parasites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0314531A true BR0314531A (pt) | 2005-08-09 |
Family
ID=32073382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0314531-0A BR0314531A (pt) | 2002-10-02 | 2003-09-29 | Formulações apropriadas de derivados do ácido nodulispórico para combater parasitas |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040077703A1 (pt) |
| EP (1) | EP1545211B1 (pt) |
| JP (1) | JP2006502241A (pt) |
| KR (2) | KR20070099668A (pt) |
| CN (1) | CN100496244C (pt) |
| AP (1) | AP2047A (pt) |
| AU (1) | AU2003279002A1 (pt) |
| BR (1) | BR0314531A (pt) |
| CA (1) | CA2500822C (pt) |
| CO (1) | CO5700750A2 (pt) |
| CR (2) | CR7810A (pt) |
| EA (1) | EA009683B1 (pt) |
| EC (1) | ECSP055736A (pt) |
| ES (1) | ES2482101T3 (pt) |
| GE (1) | GEP20084414B (pt) |
| MA (1) | MA27457A1 (pt) |
| MX (1) | MXPA05003581A (pt) |
| NZ (1) | NZ539227A (pt) |
| UA (1) | UA83199C2 (pt) |
| WO (1) | WO2004030457A1 (pt) |
| ZA (1) | ZA200502904B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9416065B2 (en) * | 2007-02-12 | 2016-08-16 | Archer Daniels Midland Company | Adjuvants and methods of using them |
| WO2009070687A1 (en) * | 2007-11-26 | 2009-06-04 | Merial Limited | Solvent systems for pour-on formulations for combating parasites |
| EP2875726A1 (fr) | 2013-11-13 | 2015-05-27 | Ceva Animal Health | Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites |
| KR101687973B1 (ko) | 2015-12-08 | 2016-12-21 | 주식회사 씨티씨바이오 | 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법 |
| JP7688973B2 (ja) * | 2017-09-29 | 2025-06-05 | ヴィクトリア リンク リミテッド | ノズリスポル酸の異種生合成 |
| KR102178885B1 (ko) * | 2020-01-17 | 2020-11-13 | 강현준 | 카프릴산을 포함하는 안정한 해충 방제제 및 이의 제조방법 |
| WO2026073866A1 (en) | 2024-10-01 | 2026-04-09 | Syngenta Crop Protection Ag | Methods of controlling an insect of the family pentatomidae |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426333B1 (en) * | 1996-09-19 | 2002-07-30 | Merial | Spot-on formulations for combating parasites |
| FR2753377B1 (fr) * | 1996-09-19 | 1999-09-24 | Rhone Merieux | Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides |
| US3950360A (en) * | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
| SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4199569A (en) * | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
| JPS57139012A (en) * | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
| US4427663A (en) * | 1982-03-16 | 1984-01-24 | Merck & Co., Inc. | 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof |
| EP0237482A1 (de) * | 1986-03-06 | 1987-09-16 | Ciba-Geigy Ag | C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen |
| DE3785936T2 (de) * | 1986-03-25 | 1993-08-26 | Sankyo Co | Makrolid-derivate, ihre herstellung und ihre verwendung. |
| GB8613914D0 (en) * | 1986-06-07 | 1986-07-09 | Coopers Animal Health | Liquid formulations |
| EP0252879B1 (de) * | 1986-07-02 | 1992-05-06 | Ciba-Geigy Ag | Pestizide |
| US4855317A (en) * | 1987-03-06 | 1989-08-08 | Ciba-Geigy Corporation | Insecticides and parasiticides |
| US4871719A (en) * | 1987-03-24 | 1989-10-03 | Ciba-Geigy Corporation | Composition for controlling parasites in productive livestock |
| DE3888936T2 (de) * | 1987-11-03 | 1994-07-21 | Beecham Group Plc | Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung. |
| NZ232422A (en) * | 1989-02-16 | 1992-11-25 | Merck & Co Inc | 13-ketal milbemycin derivatives and parasiticides |
| CA2036147A1 (en) * | 1990-06-29 | 1991-12-30 | Hiroki Tomioka | A 1-pyridylimidazole derivative and its production and use |
| GB9205007D0 (en) * | 1992-03-07 | 1992-04-22 | Pfizer Ltd | Antiparasitic agents |
| GB9300883D0 (en) | 1993-01-18 | 1993-03-10 | Pfizer Ltd | Antiparasitic agents |
| EP0611774B1 (de) * | 1993-02-19 | 1999-05-26 | F. Hoffmann-La Roche Ag | Racemisierungsfreie Herstellung von Amiden und Peptiden in Gegenwart katalytischer Mengen einer N-Hydroxy-Verbindung |
| GB9315108D0 (en) * | 1993-07-21 | 1993-09-01 | Pfizer Ltd | Antiparasitic agents |
| US5399582A (en) * | 1993-11-01 | 1995-03-21 | Merck & Co., Inc. | Antiparasitic agents |
| GB9402916D0 (en) * | 1994-02-16 | 1994-04-06 | Pfizer Ltd | Antiparasitic agents |
| JPH0827018A (ja) * | 1994-07-22 | 1996-01-30 | Sanwa Kagaku Kenkyusho Co Ltd | 生理活性ペプチド又は蛋白質を含有する薬剤組成物 |
| AUPM969994A0 (en) * | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
| US5595998A (en) * | 1994-12-15 | 1997-01-21 | Wolin; Ronald L. | Pyrazoloquinolines |
| EP0819000B1 (en) * | 1995-03-20 | 2009-07-08 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| US6221894B1 (en) * | 1995-03-20 | 2001-04-24 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| US5962499A (en) * | 1995-03-20 | 1999-10-05 | Merck & Co., Inc. | Nodulisporic acid derivatives |
| US5595991A (en) * | 1995-03-20 | 1997-01-21 | Merck & Co., Inc. | Anthelmintic use of nodulisporic acid and analogs thereof |
| FR2739255B1 (fr) * | 1995-09-29 | 1998-09-04 | Rhone Merieux | Composition antiparasitaire pour le traitement et la protection des animaux de compagnie |
| IE80657B1 (en) * | 1996-03-29 | 1998-11-04 | Merial Sas | Insecticidal combination to control mammal fleas in particular fleas on cats and dogs |
| US6010710A (en) * | 1996-03-29 | 2000-01-04 | Merial | Direct pour-on skin solution for antiparasitic use in cattle and sheep |
| US5885607A (en) * | 1996-03-29 | 1999-03-23 | Rhone Merieux | N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs |
| US5834260A (en) * | 1996-08-30 | 1998-11-10 | Merck & Co., Inc. | Antiparasitic agents |
| ATE234841T1 (de) * | 1996-09-19 | 2003-04-15 | Merck & Co Inc | Nodulisporinsäurederivate |
| US6136838A (en) * | 1998-03-19 | 2000-10-24 | Merck & Co., Inc. | Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations |
| KR100297061B1 (ko) * | 1998-03-30 | 2001-09-22 | 성재갑 | 폴리에톡실화 레틴아미드 유도체 및 그의 제조방법 |
| US6399796B2 (en) * | 2000-03-17 | 2002-06-04 | Roche Vitamins Inc. | Activation of a Diels-Alder reaction of a sterol 5,7-diene |
| US6399786B1 (en) * | 2000-07-14 | 2002-06-04 | Merck & Co., Inc. | Nonacyclic nodulisporic acid derivatives |
| US20040037869A1 (en) * | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
| US20050234119A1 (en) * | 2004-04-16 | 2005-10-20 | Soll Mark D | Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals |
| US20080003282A1 (en) * | 2005-04-18 | 2008-01-03 | Soll Mark D | Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals |
-
2003
- 2003-07-14 US US10/618,975 patent/US20040077703A1/en not_active Abandoned
- 2003-09-29 AP AP2005003289A patent/AP2047A/xx active
- 2003-09-29 ES ES03770513.4T patent/ES2482101T3/es not_active Expired - Lifetime
- 2003-09-29 CA CA2500822A patent/CA2500822C/en not_active Expired - Lifetime
- 2003-09-29 AU AU2003279002A patent/AU2003279002A1/en not_active Abandoned
- 2003-09-29 MX MXPA05003581A patent/MXPA05003581A/es unknown
- 2003-09-29 BR BR0314531-0A patent/BR0314531A/pt not_active Application Discontinuation
- 2003-09-29 GE GEAP20038771A patent/GEP20084414B/en unknown
- 2003-09-29 JP JP2005500323A patent/JP2006502241A/ja active Pending
- 2003-09-29 EA EA200500579A patent/EA009683B1/ru not_active IP Right Cessation
- 2003-09-29 CN CNB038253070A patent/CN100496244C/zh not_active Expired - Fee Related
- 2003-09-29 WO PCT/US2003/030500 patent/WO2004030457A1/en not_active Ceased
- 2003-09-29 NZ NZ539227A patent/NZ539227A/en not_active IP Right Cessation
- 2003-09-29 UA UAA200504055A patent/UA83199C2/ru unknown
- 2003-09-29 EP EP03770513.4A patent/EP1545211B1/en not_active Expired - Lifetime
- 2003-09-29 KR KR1020077019588A patent/KR20070099668A/ko not_active Withdrawn
- 2003-09-29 KR KR1020057005819A patent/KR20050059235A/ko not_active Ceased
-
2005
- 2005-04-11 ZA ZA200502904A patent/ZA200502904B/en unknown
- 2005-04-18 EC EC2005005736A patent/ECSP055736A/es unknown
- 2005-04-25 MA MA28236A patent/MA27457A1/fr unknown
- 2005-04-28 CR CR7810A patent/CR7810A/es unknown
- 2005-04-28 CO CO05040666A patent/CO5700750A2/es not_active Application Discontinuation
-
2008
- 2008-09-25 CR CR10319A patent/CR10319A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GEP20084414B (en) | 2008-07-10 |
| CA2500822A1 (en) | 2004-04-15 |
| EP1545211A1 (en) | 2005-06-29 |
| ES2482101T3 (es) | 2014-08-01 |
| US20040077703A1 (en) | 2004-04-22 |
| CR7810A (es) | 2005-05-25 |
| CR10319A (es) | 2008-10-21 |
| EA200500579A1 (ru) | 2005-08-25 |
| AP2005003289A0 (en) | 2005-06-30 |
| CN100496244C (zh) | 2009-06-10 |
| EP1545211B1 (en) | 2014-04-30 |
| KR20050059235A (ko) | 2005-06-17 |
| MA27457A1 (fr) | 2005-07-01 |
| HK1072348A1 (en) | 2005-08-26 |
| CA2500822C (en) | 2013-12-24 |
| CO5700750A2 (es) | 2006-11-30 |
| AP2047A (en) | 2009-09-18 |
| MXPA05003581A (es) | 2005-06-17 |
| ECSP055736A (es) | 2005-09-20 |
| ZA200502904B (en) | 2005-10-19 |
| JP2006502241A (ja) | 2006-01-19 |
| CN1700859A (zh) | 2005-11-23 |
| WO2004030457A1 (en) | 2004-04-15 |
| NZ539227A (en) | 2007-01-26 |
| EA009683B1 (ru) | 2008-02-28 |
| UA83199C2 (ru) | 2008-06-25 |
| AU2003279002A1 (en) | 2004-04-23 |
| KR20070099668A (ko) | 2007-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28280A1 (es) | 2- hidroxi - 3- diaminoalcanos de benzamida | |
| UY28279A1 (es) | Fenacilo 2 -hidroxi - 3 - diaminoalcanos | |
| BRPI0408369A (pt) | derivados de indol úteis para o tratamento de doenças | |
| BR0313160A (pt) | Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto | |
| BRPI0407375A (pt) | Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos | |
| BR0113039A (pt) | Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto | |
| ATE417610T1 (de) | Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen | |
| ECSP034815A (es) | "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas" | |
| CR20230485A (es) | Derivados de fósforo como nuevos inhibidores de sos1 | |
| BRPI0614168A2 (pt) | Composto ou um sal, hidrato, solvato, isoforma, tautômero, isômero óptico farmaceuticamente aceitável ou uma combinação dos mesmos, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psquiátricos, uso de um composto, e, processo para a preparação de um composto | |
| PA8649101A1 (es) | Composiciones fungicidas | |
| BRPI0410660A (pt) | derivados de 2-amino-piridina como agonistas de adrenoreceptor ß2 | |
| BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
| BR9809115A (pt) | Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt | |
| BR0316629A (pt) | Uréias e carbamatos substituìdos | |
| AU2002342878A1 (en) | Pyridylpyrimidine derivatives as effective compounds against prion diseases | |
| BRPI0415179A (pt) | derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas | |
| CO2022011258A2 (es) | Pirazolo-pirimidinas sustituidas y usos de las mismas | |
| BR0314531A (pt) | Formulações apropriadas de derivados do ácido nodulispórico para combater parasitas | |
| CO2024017422A2 (es) | Composiciones y métodos para inhibir la expresión de serina proteasa transmembrana 6 (tmprss6) | |
| BR0006301A (pt) | Macrólidos antibacterianos e pró-cinéticos | |
| BR9913425A (pt) | Derivados de ácido hidroxìmico insaturado comoinibidores parp | |
| HN1997000070A (es) | Inhibición de las metaloproteinasas de matriz por acidos 2-((1)-aroilalquil) -4-biaril-4-oxoburiticos | |
| BRPI0508927A (pt) | compostos úteis para o tratamento de doenças | |
| CR20220668A (es) | Derivados de tetrazol como inhibidores de trpa1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |